ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.85
-0.14%
US Tech 100
19,181.60
-0.43%
S&P 500
5,460.48
-0.41%
US Dollar vs CAD
1.36767
0.02%
Bitcoin
63,304.50
1.01%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Scinai Immunotherapeutics Ltd (SCNI)

  7. Scinai Immunotherapeutics Ltd (SCNI) News

SCNI

Scinai Immunotherapeutics (SCNI)

Scinai Immunotherapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SCNI
DateTimeSourceHeadlineSymbolCompany
06/14/20246:26AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
06/13/20249:19AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
06/13/20249:16AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
06/13/20246:00AMPR Newswire (US)Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity.NASDAQ:SCNIScinai Immunotherapeutics Ltd
06/07/20246:00AMPR Newswire (US)Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity RequirementNASDAQ:SCNIScinai Immunotherapeutics Ltd
05/28/20241:14PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
05/24/20243:01PMPR Newswire (US)Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining ComplianceNASDAQ:SCNIScinai Immunotherapeutics Ltd
05/16/202412:49PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCNIScinai Immunotherapeutics Ltd
05/15/20244:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
05/15/20243:01PMPR Newswire (US)Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business UpdateNASDAQ:SCNIScinai Immunotherapeutics Ltd
05/07/20249:24AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
05/06/20248:21AMPR Newswire (US)Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and AppealNASDAQ:SCNIScinai Immunotherapeutics Ltd
04/10/20246:00AMPR Newswire (US)Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMGNASDAQ:SCNIScinai Immunotherapeutics Ltd
04/08/20244:15PMAllPennyStocks.comBiotech Rips Following Five-Year Master Service Agreement ReleaseNASDAQ:SCNIScinai Immunotherapeutics Ltd
04/08/20246:00AMPR Newswire (US)Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing ServicesNASDAQ:SCNIScinai Immunotherapeutics Ltd
03/12/20247:00AMPR Newswire (US)Scinai leadership to attend BIO-Europe Spring 2024NASDAQ:SCNIScinai Immunotherapeutics Ltd
02/29/20247:45AMPR Newswire (US)Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024NASDAQ:SCNIScinai Immunotherapeutics Ltd
02/13/20246:00AMPR Newswire (US)Scinai Welcomes Liat Halpert as Head of Business Development and SalesNASDAQ:SCNIScinai Immunotherapeutics Ltd
01/30/20243:19PMEdgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:SCNIScinai Immunotherapeutics Ltd
01/25/20249:26AMPR Newswire (US)Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet PrizeNASDAQ:SCNIScinai Immunotherapeutics Ltd
01/24/20241:33PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SCNIScinai Immunotherapeutics Ltd
01/18/202410:50AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
01/12/20246:32AMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SCNIScinai Immunotherapeutics Ltd
01/09/20247:45AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
01/04/20243:37PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
01/04/20243:01PMPR Newswire (US)Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross ProceedsNASDAQ:SCNIScinai Immunotherapeutics Ltd
01/04/20245:15AMPR Newswire (US)Scinai Immunotherapeutics CEO Issues Letter to ShareholdersNASDAQ:SCNIScinai Immunotherapeutics Ltd
01/02/20248:58AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCNIScinai Immunotherapeutics Ltd
01/02/20248:57AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCNIScinai Immunotherapeutics Ltd
01/02/20248:26AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:SCNI

Your Recent History

USOTC
GRST
Ethema Health (PK)
COIN
BTCUSD
Bitcoin
USOTC
SPZI
Spooz (PK)
USOTC
AABB
Asia Broadband (PK)
NASDAQ
COOP
Mr Cooper
USOTC
FNMA
Fannie Mae (QB)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
RNVA
Rennova Health (PK)
USOTC
SMCE
SMC Entertainment (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved